Lobe Sciences Ltd. (LOBEF)
- Previous Close
0.0130 - Open
0.0170 - Bid --
- Ask --
- Day's Range
0.0111 - 0.0190 - 52 Week Range
0.0010 - 0.0232 - Volume
213,420 - Avg. Volume
31,908 - Market Cap (intraday)
2.479M - Beta (5Y Monthly) 2.43
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Jul 30, 2024 - Aug 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
www.lobesciences.comRecent News: LOBEF
Performance Overview: LOBEF
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LOBEF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LOBEF
Valuation Measures
Market Cap
2.41M
Enterprise Value
2.67M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.95
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-291.93%
Return on Assets (ttm)
-98.73%
Return on Equity (ttm)
--
Revenue (ttm)
976.74k
Net Income Avi to Common (ttm)
-2.85M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
120.19k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
100.01k
Research Analysis: LOBEF
Company Insights: LOBEF
LOBEF does not have Company Insights